📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Galactosylated a,ß-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin: improved antitumor activity against hepatocellular carcinoma with reduced hepatotoxicity. (2011)

First Author: Cheng X

Attributed to: Fundamental Physics and Observational Cosmology funded by STFC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/cad.0b013e3283406e85

PubMed Identifier: 20966743

Publication URI: http://europepmc.org/abstract/MED/20966743

Type: Journal Article/Review

Volume: 22

Parent Publication: Anti-cancer drugs

Issue: 2

ISSN: 0959-4973